Company Snapshot: WPI  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Watson Pharmaceuticals to Present at the Raymond James 25th Annual Institutional Investors Conference

   WATSON PHARMACEUTICALS LOGO
Watson Pharmaceuticals, Inc. logo. (PRNewsFoto)[TK]
CORONA, CA USA
    CORONA, Calif., March 1 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals,
Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today
that Watson's senior management will provide an overview of the Company's
business at the Raymond James 25th Annual Institutional Investors Conference
on Wednesday, March 3, 2004 at 11:00 a.m. EST.
    This presentation will be webcast live and can be accessed at Watson
Pharmaceuticals' Web site http://www.watsonpharm.com.  Click on Investors, and then
click on Events.  The webcast can also be accessed at the following URL:
http://www.wallstreetwebcasting.com/webcast/rjii04/wpi/
    An archived version will be available for 30 days after the live
presentation and can be accessed at the same locations.

    About Watson Pharmaceuticals, Inc.
    Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a
leading specialty pharmaceutical company that develops, manufactures, markets,
sells and distributes branded and generic pharmaceutical products. Watson
pursues a growth strategy combining internal product development, strategic
alliances and collaborations and synergistic acquisitions of products and
businesses.
    For press releases and other company information, visit Watson
Pharmaceuticals' Web site at http://www.watsonpharm.com.

    (Logo:  http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO )


SOURCE Watson Pharmaceuticals, Inc.




Back to Topback to top

Related links:
  • http://www.watsonpharm.com
    Photo Notes:http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO
    CONTACT:
    Investors, Patty Eisenhaur +1-909-493-5611,
    or Media, Chris Eso, +1-909-493-4013, both of Watson
    Pharmaceuticals, Inc.